Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia
€
2.42
Article: Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia quantity
Add to cart
SKU:
product-article-18168
Category:
General
Description
Description
Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia
Related products
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€
2.42
Add to cart
Article: Highlights in melanoma
€
2.42
Add to cart
Article: Highlights in breast cancer
€
2.42
Add to cart
Article: Highlights in respiratory oncology
€
2.42
Add to cart